排毒肝胆清

为什么我们的肝脏需要排毒?

肝脏是人体消化系统的重要器官,具有500多种消化功能,例如像新陈代谢、排毒、合成蛋白质、产生红细胞、激素及分解糖转化成糖原。肝脏也负责处理多种维生素和营养物质转换成可以被身体利用的形式。现代生活中使用的化学品会产生大量的有毒物质,加重肝脏排毒的负荷。如何保护肝脏,维持肝脏功能在最佳水平的功能是人体健康的关键。


为什么选择安道?

安道的排毒肝胆清含有九种高效天然成分,可以帮助人体调节和维持健康的肝功能。

奶蓟草提取物:

过去四十年的大量药理和临床研究证实,奶蓟草不仅对于治疗人类肝脏疾病非常有效,而且对于保护人体免受任何其它伤害也具有非凡的抵抗力。美国国立医学图书馆和美国国立卫生研究院(NIH)的医学数据库中收藏有超过400个关于奶蓟草及其活性成分的科学研究。这些收藏说明了在世界任何一个地方,奶蓟草都是最有价值和有益的膳食补充剂。

奶蓟草提取物常用于帮助改善蘑菇中毒、酒精性肝硬化、慢性肝炎、药物和酒精引起的肝损害和急性病毒性肝炎。

酒石酸胆碱:

胆碱类似于B族维生素,可以在肝脏中形成或从食物中摄取,如肝脏、肌肉、鱼、坚果和豆类等。研究表明胆碱可以改善慢性肝炎和肝硬化。

N-乙酰L-半胱氨酸(NAC):

世界卫生组织(WHO)把N-乙酰L-半胱氨酸(NAC)列为任何保健卫生系统中最基础的和必须的一种保健品。NAC最显著的功效在于抗氧化和护肝。

姜黄提取物(姜黄素):

在印度和亚洲其他地区,姜黄被用来改善很多健康问题,具有强力的消炎和抗氧化性能。姜黄素是姜黄中的活性物质,有利于帮助减少肝脏炎症的发生。

安道公司独有草本配方:

安道公司独有草本配方包括蒲公英根萃取物、洋蓟花萃取物、五味子浆果萃取物、L-蛋氨酸和牛蒡根萃取物。这些最优质的草本保健品有助于保护人体肝脏、胆和消化系统,并保持其最佳功能。

Advanced Liver Detox Supplement Ingredients:
Liver Detox Supp Facts

参考文献:

  1. Fu ZD, Csanaky IL, Klaassen CD. Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice. Drug Metab Dispos. 2012 Jun;40(6):1216-25.
  2. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 1997 Apr;26(4):871-9.
  3. Yao J, Zhi M, Minhu C. Effect of silybin on high-fat-induced fatty liver in rats. Braz J Med Biol Res. 2011 Jul;44(7):652-9.
  4. Sangeetha N, Viswanathan P, Balasubramanian T, Nalini N. Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats. Eur J Pharmacol. 2012 Jan 15;674(2-3):430-8.
  5. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006 Nov;124(5):491-504.
  6. Conti M, Malandrino S, Magistretti MJ. Protective activity of silipide on liver damage in rodents. Jpn J Pharmacol. 1992 Dec;60(4):315-21.
  7. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic.Biol Med. 2012;52(9):1658-65.
  8. Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G. Comparative bioavailability of silipide, a new flavanolignan complex, in rats. Eur J Drug Metab Pharmacokinet. 1992 Jan-Mar;17(1):39-44.
  9. Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):289-97.
  10. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 1990;15(4):333-38.
  11. Fan S, Yu Y, Qi M, et al. P53-mediated GSH depletion enhanced the cytotoxicity of NO in silibinin-treated human cervical carcinoma HeLa cells. Free Radic Res. 2012 Sep;46(9):1082-92.
  12. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future.Phytother Res. 2010 Oct;24(10):1423-32.
  13. Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: A dose escalation study. Drug Metab Dispos. 2013 Jul 8. [Epub ahead of print]
  14. Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008 Oct 8;269(2):352-62.
  15. Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice. Clin Cancer Res. 2010 Sep 15;16(18):4595-606.
  16. Song Z, Deaciuc I, Song M, et al. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcohol Clin Exp Res. 2006 Mar;30(3):407-13.
  17. Kidd P Fau – Head K, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev. 2005 Sep;10(3):193-203.
  18. Dolphin D. Cytochrome P450: substrate and prosthetic-group free radicals generated during the enzymatic cycle. Philos Trans R Soc Lond B Biol Sci. 1985 Dec 17;311(1152):579-91.
  19. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998 Feb;93(2):139-43.
  20. Kren V, Walterova D. Silybin and silymarin–new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):29-41.
  21. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14(3):226-46.
  22. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol. 2007;39(4):172-79.
  23. Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res. 2012 Jun;159(6):477-86.
  24. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med. 2012 May 1;52(9):1658-65.
  25. Kim M, Yang SG, Kim JM, Lee JW, Kim YS, Lee JI. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012 Sep;30(3):473-9.
  26. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology. 2008 Jun;47(6):1947-54.
  27. Stravitz RT, Sanyal AJ, Reisch J, Bajaj JS, Mirshahi F, Cheng J, Lee WM; Acute LiverFailure Study Group. Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int. 2013 Oct;33(9):1324-31. doi: 10.1111/liv.12214. Epub 2013 Jun 19.
  28. Tian YM, Dou LP, Yao S, Yao ZL, Zhang QF, Yu L, Jing Y. [Protective effect of ademetionine 1, 4-butanedisulfonate on liver injury caused by chemotherapeutic agents]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1305-8. doi: 10.7534/j.issn.1009-2137.2013.05.044. Chinese.
  29. Grela ER, Sobolewska S, Roziński T. Effect of inulin extracts or inulin-containing plant supplement on blood lipid indices and fatty acid profile in fattener tissues. Pol J Vet Sci. 2014;17(1):93-8.
  30. Chiu HF, Chen TY, Tzeng YT, Wang CK. Improvement of liver function in humans using a mixture of schisandra fruit extract and sesamin. Phytother Res. 2013 Mar;27(3):368-73. doi: 10.1002/ptr.4702. Epub 2012 May 21.
  31. Stel makh VV, Kozlov VK.  [Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy]. Ter Arkh. 2013;85(4):71-6. Russian.
  32. Lin CC, Lu JM, Yang JJ, Chuang SC, Ujiie T. Anti-inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med. 1996;24(2):127-37.
消化酵素

什么是消化酵素?

消化酵素也称消化酶,在人体内起着帮助消化的作用。它们将食物转换为水溶性物质,如糖类分解为单糖,蛋白质分解为氨基酸,脂肪分解为脂肪酸或甘油,然后被身体吸收。消化酵素可从食物中摄取,或靠人体自身产生。

人们饮食后最常见的问题就是胃涨气、胃部不适,还有打嗝、放屁等令人尴尬的状况。很多人吃在特定的食物后都会有消化不良的反应,如豆类(扁豆)、绿色蔬菜(花椰菜,甘蓝等)、洋葱、大蒜和奶制品。发生这些问题的原因在于,烹饪过程中很多食物中的消化酵素都已经被高温破坏,尤其是现代化的食品,绝大多数为了延长保质期而经过大量的加热加工加料处理,其中所含的天然消化酵素几乎都被破坏殆尽。

人体本身可以产生消化酵素来帮助消化食物,但是随着年龄的增长,胃部产生消化酵素的功能下降,更增加了其它器官的负担。服用消化酵素补充剂,可以帮助您告别消化不良以及种种不适和尴尬。

什么选择安道公司的消化酵素?

安道公司消化酵素的多酶配方能够最全面地支持您的消化系统。该配方含有15种不同的天然营养物质和酶,不含任何副作用,可以快速被人体吸收,达到消化分解食物的最佳功效。

安道​​公司的消化酵素特色:

  • 富含15种不同的营养素和消化酶,特别针对婴幼儿、儿童娇嫩的脾胃设计;
  • 特含乳糖酶:帮助消除乳糖消化不良,适合婴幼儿食用;
  • 协助分解最难消化的食物:蛋白酶——消化蛋白质;脂肪酶——协助脂肪分解;综合酵素——­分解豆类,防止胀气;
  • 特含益生元成份:增加肠道有活性益生菌生长,益肠健胃;
  • 含薄荷、留兰香、茴香油成分:为您的消化系统提供最好的保养,可增强食欲、改善厌食和食欲不振等问题;帮助更好吸收各种营养素,达到营养均衡;
  • 改善便秘,预防上火。

Enzyme Plus Supplement Ingredients:
Enzyme Plus Supp Facts

参考文献:

  1. Marrelli M, Loizzo MR, Nicoletti M, Menichini F, Conforti F. Inhibition of Key Enzymes Linked to Obesity by Preparations From Mediterranean Dietary Plants: Effects on α-Amylase and Pancreatic Lipase Activities. Plant Foods Hum Nutr. 2013 Oct 12.
  2. Delano FA, Schmid-Schönbein GW. Pancreatic Digestive Enzyme Blockade in the Small Intestine Prevents Insulin Resistance in Hemorrhagic Shock. Shock. 2013 Oct 1.
  3. Wilcox MD, Brownlee IA, Richardson JC, Dettmar PW, Pearson JP. The modulation of pancreatic lipase activity by alginates. Food Chem. 2014 Mar 1;146:479-84.
  4. Ramesh H, Reddy N, Bhatia S, Rajkumar JS, Bapaye A, Kini D, Kalla M, Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013 Mar-Apr;13(2):133-9.